SCHEMBL18598325

SCHEMBL18598325

Cc1sc(NC(=O)C2CC2)c(C(=O)OC(C)C)c1C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.73
▸ ALDH1A1 P00352 9/20 0.68
▸ KDM4E B2RXH2 5/20 0.65
▸ POLB P06746 3/20 0.65
▸ TDP1 Q9NUW8 2/20 0.65
▸ LMNA P02545 2/20 0.65
▸ RXFP1 Q9HBX9 1/20 0.58
▸ HPGD P15428 4/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ NPSR1 Q6W5P4 3/20 0.55
▸ GAA P10253 1/20 0.55
▸ PKM P14618 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ EGLN1 Q9GZT9 1/20 0.49
▸ USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680529 0.86 ALDH1A1 (0.63) MAPTALDH1A1KDM4ERXFP1HPGD
SCHEMBL20272284 0.71 MAPT (0.48) MAPTALDH1A1KDM4EPOLBRXFP1
SCHEMBL8289404 0.70 ALDH1A1 (0.80) MAPTALDH1A1KDM4EPOLBTDP1
SCHEMBL31277120 0.67 ALDH1A1 (0.55) MAPTALDH1A1KDM4EPOLBTDP1
SCHEMBL4080979 0.66 ALDH1A1 (0.60) MAPTALDH1A1KDM4EPOLBTDP1
SCHEMBL3767865 0.66 MAPK1 (0.66) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL7825608 0.65 ALDH1A1 (0.61) MAPTALDH1A1KDM4EPOLBLMNA
SCHEMBL21603842 0.63 CXCR2 (0.61) MAPTALDH1A1KDM4EPOLBLMNA
SCHEMBL12903924 0.63 MAPT (0.60) MAPTALDH1A1KDM4EPOLBLMNA
SCHEMBL2644504 0.63 ALDH1A1 (0.97) MAPTALDH1A1KDM4ELMNARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138838-A1 SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS Dana-Farber Cancer Institute, Inc. (US) 2017-03-08 — — EP disclosed
Send feedback